IDO1 is a rate-limiting enzyme in the extracellular tryptophan catabolism pathway via kynurenine, and it has been proven to be abnormally highly expressed in malignant tumors such as cervical cancer and esophageal cancer. This evidence concerns the gene IDO1 and esophageal cancer.